Semaglutide is a recombinant DNA produced polypeptide analog of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents.
CAT No: 10-101-325
CAS No: 910463-68-2
Synonyms/Alias: Sermaglutide; UNII-53AXN4NNHX; NNC 0113-0217; 53AXN4NNHX
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C187H291N45O59 |
M.W/Mr. | 4113.57 |
Application | The treatment of type 2 diabetes |
Appearance | White to off-white powder |
Purity | ≥ 98% (or refer to the Certificate of Analysis) |
Activity | Agonist |
Target | Glucagon Receptor |
1. Emu oil in combination with other active ingredients for treating skin imperfections
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.